AntoinetteJosephineWozniakMD

PubMed

• Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer.
  Horn, L.,Bauml, J.,Forde, P. M.,Davis, K. L.,Myall, N. J.,Sasane, M.,Dalal, A.,Culver, K.,Wozniak, A. J.,Baik, C. S.,Mutebi, A.,Zhang, P.,Wakelee, H. A.,Johnson, B. E.> ;Lung Cancer. 2019 Jan 16
• Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC).
  Gadgeel, S. M.,Pennell, N. A.,Fidler, M. J.,Halmos, B.,Bonomi, P.,Stevenson, J.,Schneider, B.,Sukari, A.,Ventimiglia, J.,Chen, W.,Galasso, C.,Wozniak, A.,Boerner, J.,K...> ;J Thorac Oncol. 2018 May 19
• Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy.
  McMullen, S.,Hess, L. M.,Kim, E. S.,Levy, B.,Mohamed, M.,Waterhouse, D.,Wozniak, A.,Goring, S.,Müller, K.,Muehlenbein, C.,Aggarwal, H.,Zhu, Y.,Oton, A. B.,Ersek, J. L....> ;Patient. 2018 Aug 22
• Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology and End Results (SEER) Data.
  Thakur, M. K.,Ruterbusch, J. J.,Schwartz, A. G.,Gadgeel, S. M.,Beebe-Dimmer, J. L.,Wozniak, A. J.> ;J Thorac Oncol. 2017 Oct 11
• Risk of Lung Cancer Associated with COPD Phenotype Based on Quantitative Image Analysis.
  Schwartz AG, Lusk CM, Wenzlaff AS, Watza D, Pandolfi S, Mantha L, Cote ML, Soubani AO, Walworth G, Wozniak A, Neslund-Dudas C, Ardisana AA, Flynn MJ, Song T, Spizarny ...> ;Cancer Epidemiol. Biomarkers Prev.. 2016-09-01
• Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
  Zaki M, Dominello M, Dyson G, Gadgeel S, Wozniak A, Miller S, Paximadis P> ;Clin Lung Cancer. 2016-07-22
• Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma.
  Pass HI, Goparaju C, Espin-Garcia O, Donington J, Carbone M, Patel D, Chen Z, Feld R, Cho J, Gadgeel S, Wozniak A, Chachoua A, Leighl N, Tsao M, de Perrot M, Xu W, Liu G> ;J Thorac Oncol. 2016-06-01
• Morphological assessment of thin basement membrane disease.
  Zurawski J, Burchardt P, Moczko J, Seget M, Iwanik K, Sikora J, Woźniak A, Salwa-Zurawska W> ;Pol J Pathol. 2016-06-01
• Effectiveness of bevacizumab exposure beyond disease progression in patients with non-small-cell lung cancer: analyses of the ARIES observational cohort study.
  Leon L, Kosty M, Jahanzeb M, Spigel D, Wozniak AJ, Brahmer J, Fish S, Flick ED, Hazard SJ, Lynch TJ> ;Pharmacoepidemiol Drug Saf. 2016-05-01
• Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data.
  Goncalves, P. H.,Peterson, S. L.,Vigneau, F. D.,Shore, R. D.,Quarshie, W. O.,Islam, K.,Schwartz, A. G.,Wozniak, A. J.,Gadgeel, S. M.> ;Cancer. 1900 Jan 01
• Effectiveness and safety of post-induction phase bevacizumab treatment for patients with non-small-cell lung cancer: results from the ARIES observational cohort study.
  Kosty, M. P.,Wozniak, A. J.,Jahanzeb, M.,Leon, L.,Fish, S.,Hazard, S. J.,Lynch, T. J.> ;Target Oncol. 2015 Jan 07
• Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.
  Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO> ;J. Clin. Oncol.. 2015-10-01
• Rociletinib in EGFR-mutated non-small-cell lung cancer.
  Sequist LV, Soria J, Goldman JW, Wakelee HA, Gadgeel SM, Varga A, Papadimitrakopoulou V, Solomon BJ, Oxnard GR, Dziadziuszko R, Aisner DL, Doebele RC, Galasso C, Garon...> ;N. Engl. J. Med.. 2015-04-30
• Clinical outcomes in elderly patients with advanced non-small cell lung cancer: results from ARIES, a bevacizumab observational cohort study.
  Wozniak AJ, Kosty MP, Jahanzeb M, Brahmer JR, Spigel DR, Leon L, Fish S, Flick ED, Hazard SJ, Lynch TJ> ;Clin Oncol (R Coll Radiol). 2015-04-01
• A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Local...
  Wozniak, A. J.,Moon, J.,Thomas, C. R.,Kelly, K.,Mack, P. C.,Gaspar, L. E.,Raben, D.,Fitzgerald, T. J.,Pandya, K. J.,Gandara, D. R.> ;Clin Lung Cancer. 2015 Feb 24
• Poster session 6: Saturday 6 December 2014, 08:30-12:30Location: Poster area.
  Goirigolzarri Artaza, J.,Gallego Delgado, M.,Jaimes Castellanos, C.,Cavero Gibanel, M.,Pastrana Ledesma, M.,Alonso Pulpon, L.,Gonzalez Mirelis, J.,Al Ansi, R. Z.,Sokol...> ;Eur Heart J Cardiovasc Imaging. 2014 Dec 08
• Safety and effectiveness of bevacizumab-containing treatment for non-small-cell lung cancer: final results of the ARIES observational cohort study.
  Thomas J. Lynch, David R. Spigel, Julie R. Brahmer, Neal Fischbach, Jennifer Garst, Mohammad Jahanzeb, Priya Kumar, Regina M. Vidaver, Antoinette J. Wozniak, S. Fish, ...> ;Journal of Thoracic Oncology. 2014 Sep 1
• Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma.
  Lee M. Krug, Antoinette J. Wozniak, Hedy L. Kindler, Ronald Feld, Marianna Koczywas, Jose Luis Morero, Cristina P. Rodriguez, Helen J. Ross, Julie E. Bauman, Sergey Or...> ;Lung Cancer. 2014 Sep 1
• MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours.
  Gits CMM, van Kuijk PF, Jonkers MBE, Boersma AWM, van Ijcken WF, Wozniak A, Sciot R, Rutkowski P, Schöffski P, Taguchi T, Mathijssen RHJ, Verweij J, Sleijfer S, Debiec...> ;Br. J. Cancer. 2013-09-17
• Chemotherapy Outcomes by Histologic Subtypes of Non-Small-Cell Lung Cancer: Analysis of the Southwest Oncology Group Database for Antimicrotubule-Platinum Therapy.
  Kelly, K.,Chansky, K.,Mack, P. C.,Lara, P. N.,Hirsch, F. R.,Franklin, W. A.,Wozniak, A. J.,Edelman, M. J.,Williamson, S. K.,Gandara, D. R.> ;Clin Lung Cancer. 2013 Jul 31
• Preclinical rationale for PI3K/Akt/mTOR pathway inhibitors as therapy for epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancer.
  Gadgeel, S. M.,Wozniak, A.> ;Clin Lung Cancer. 2013 Jul
• Challenges in the current antiangiogenic treatment paradigm for patients with non-small cell lung cancer.
  Wozniak, A.> ;Crit Rev Oncol Hematol. 2012 May
• Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience.
  Wozniak A, Rutkowski P, Piskorz A, Ciwoniuk M, Osuch C, Bylina E, Sygut J, Chosia M, Rys J, Urbanczyk K, Kruszewski W, Sowa P, Siedlecki J, Debiec-Rychter M, Limon J> ;Ann. Oncol.. 2012-02-01
• Cardiac toxicity associated with dose and gender in patients undergoing chemoradiation for esophageal carcinoma.
  Tait LM, Meyer JE, McSpadden E, Cheng JD, Philip PA, Scott WJ, Baciewicz F, Meropol NJ, Shields AF, Crawford K, Cohen SJ, Wozniak AJ, Gadgeel SM, Choi M, Konski AA> ;J. Clin. Oncol.. 2012-02-01
• A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
  Javid SH, Unger JM, Gralow JR, Moinpour CM, Wozniak AJ, Goodwin JW, Lara PN, Williams PA, Hutchins LF, Gotay CC, Albain KS> ;Oncologist. 2012-01-01
• Join now to see all

Lectures

• A phase II trial of nintedanib in recurrent malignant pleural mesothelioma (MPM). 
  ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019